Want to join the conversation?
Robert Fishman of MoffettNathanson asks for an update on rescreening. $CNK said it takes a disciplined approach to rescreening and the results so far have reached or exceeded 40% attendance. The company will be diligent in its financial analysis for future Capex with regards to rescreening. $CNK does not have a specific number for 2017.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)